Varicella Zoster Virus (VZV), Cerebrospinal Fluid (CSF), DNA PCR
Use
This assay is used for the detection of Varicella Zoster Virus (VZV) DNA in cerebrospinal fluid.
Special Instructions
Not provided.
Limitations
Results from this test must be considered in conjunction with clinical history, epidemiological data, and other laboratory information. Negative results do not exclude VZV infections of the CNS, and test results must not be used as the sole basis for treatment decisions. False-negatives may occur if the virus is present below the assay's sensitivity or has genomic mutations affecting detection.
Methodology
PCR-based (PCR)
Biomarkers
Varicella Zoster Virus
Microorganism
LOINC Codes
- 21598-8 - VZV DNA CSF Ql NAA+probe
- 21598-8 - VZV DNA CSF Ql NAA+probe
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
0.5 mL
Minimum Volume
0.2 mL
Container
Sterile container
Collection Instructions
Submit separate specimens for each test when requesting multiple tests on a frozen sample.
Storage Instructions
Frozen
Causes for Rejection
Improperly labeled or unlabeled specimen; specimen that has grossly leaked in transit; specimen submitted in an improper collection/transport device; non-CSF specimens
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Not acceptable |
| Refrigerated | 7 days |
| Frozen | >7 days |
Other tests from different labs that may be relevant